CN100348247C - Medicine used for treating inflammation of woman genetic system and its preparation method - Google Patents

Medicine used for treating inflammation of woman genetic system and its preparation method Download PDF

Info

Publication number
CN100348247C
CN100348247C CNB2005100033519A CN200510003351A CN100348247C CN 100348247 C CN100348247 C CN 100348247C CN B2005100033519 A CNB2005100033519 A CN B2005100033519A CN 200510003351 A CN200510003351 A CN 200510003351A CN 100348247 C CN100348247 C CN 100348247C
Authority
CN
China
Prior art keywords
portions
hours
add
medicine
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100033519A
Other languages
Chinese (zh)
Other versions
CN1824118A (en
Inventor
林开忠
赵海
穆润华
谌贻洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guizhou Gute Pharmacy Group Co., Ltd.
Original Assignee
林开忠
赵海
穆润华
谌贻洪
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 林开忠, 赵海, 穆润华, 谌贻洪 filed Critical 林开忠
Priority to CNB2005100033519A priority Critical patent/CN100348247C/en
Publication of CN1824118A publication Critical patent/CN1824118A/en
Application granted granted Critical
Publication of CN100348247C publication Critical patent/CN100348247C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention discloses a medicine for treating inflammation of woman genital system and the preparation method thereof. The present invention comprises the following raw materials (by weight portions) of 150 to 250 portions of dandelion, 150 to 250 portions of hongtube groundivy herb, 50 to 150 portions of Chinese angelica root, 100 to 200 portions of white peony root and 50 to 120 portions of blood notoginseng; the five raw materials are decocted for twice with water, the first time is decocted for 2 hours by adding 10 times of water, and the second time is decocted for 1 hour by adding 8 times of water; through filtering and merging, the pressure of filtrate is reduced and the relative density of the filtrate is concentrated to 1.08 to 1.10 (60 DEG C); alcohol is added to cause alcohol content to reach 65 percent; through the processes of standing still for 48 hours, filtering and filtrate recovery, the alcohol is concentrated to extractum of the relative density of 1.05 to 1.35, and the present invention can be obtained. The present invention has the advantages of clearing away heat, promoting dampnesss, promoting blood circulation, removing obstruction in collaterals, regulating menstruation, stopping pain, conspicuous curative effect and no toxic and side effect.

Description

A kind of medicine that is used for the treatment of inflammation of woman genetic system and preparation method thereof
Technical field
The invention belongs to medical technical field, relate in particular to a kind of medicine that is used for the treatment of inflammation of woman genetic system, also relate to its preparation method simultaneously.
Background technology
The inflammation of female genital system (uterus, fallopian tube and oophoritis etc.) belongs to the traditional Chinese medical science " married woman's stomachache " categories such as " morbid leukorrheas ", is department of obstetrics and gynecology commonly encountered diseases, frequently-occurring disease, and adult women's sickness rate is high.Account for adult women's sum according to statistics more than 60%, it is more to treat this sick Western medicine kind at present, and clinical efficacy is not good enough, uses antibiotic easily to cause the generation of untoward reaction repeatedly yet.Though Chinese patent medicine has some, mostly be old kind, imitated kind can not meet clinical needs fully, and product also faces replacement problem.
Summary of the invention
A kind of effect that the objective of the invention is to overcome above-mentioned shortcoming and provide with clearing away heat-damp and promoting diuresis, promoting blood circulation to remove obstruction in the collateral, menstruction regulating and pain relieving, evident in efficacy, the medicine that is used for the treatment of inflammation of woman genetic system that has no side effect.
The process for preparing medicine that is used for the treatment of inflammation of woman genetic system that provides also is provided another object of the present invention.
Technical scheme of the present invention realizes in the following manner.
The medicine that is used for the treatment of inflammation of woman genetic system of the present invention, its crude drug and weight portion thereof consist of:
Herba Taraxaci 150-250 part Herba Glechomae 150-250 part Radix Angelicae Sinensis 50-150 part
Radix Paeoniae Alba 100-200 part XUESANQI 50-150 part.
The preparation method that is used for the treatment of the medicament active composition of inflammation of woman genetic system of the present invention with the above five tastes, decocts with water 2 times, add for the first time 10 times of decoctings 2 hours, for the second time add 8 times of decoctings and boiled 1 hour, filter merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), add ethanol and make and contain the alcohol amount and reach 65%, left standstill 48 hours, filter, filtrate recycling ethanol is concentrated into the extractum that relative density is 1.05-1.35, promptly.
The medicine of above-mentioned treatment inflammation of woman genetic system with above-mentioned gained extractum, with corresponding dosage form adjuvant, is used conventional method, prepares dosage forms such as corresponding capsule, soft capsule, tablet, granule, oral liquid, pill.
No matter the present invention is compared with prior art treating rule, formulation composition, still is being to select the equal obvious characteristic of tool in the medication.Research and development this time are in conjunction with modern basic research result, utilization modern pharmaceutical technology and technology on preparation technology, essence is carried the medicine active component, discards the dross and selects the essential, and keeps or improves the prescription curative effect, use simultaneously easy to carry, steady quality.Be used for damp invasion of lower energizer and cause diseases such as adnexitis, endometritis, pelvic inflammatory disease, cervicitis, vaginitis, and dysmenorrhes, leukorrhagia, pelvic congestion card etc., good effect obtained.Have clearing away heat-damp and promoting diuresis, promoting blood circulation to remove obstruction in the collateral, the effect of menstruction regulating and pain relieving, evident in efficacy, and have no side effect.
The specific embodiment
Below further set forth beneficial effect of the present invention by clinical observation on the therapeutic effect test.
1, case is selected
This tests 160 routine pelvic inflammatory disease patients, all derives from clinic case.Wherein 90 examples are organized in treatment, matched group 82 examples.Treatment group age 18-45 year, average 31 years old; Acute pelvic inflammatory disease 47 examples, undergoing chronic pelvic inflammation 29 examples, pelvic congestion disease 14 examples.Matched group 17-48 year, average 29 years old; Acute pelvic inflammatory disease 26 examples, chronic pelvic inflammatory disease 43 examples, pelvic congestion disease 13 examples.
2, diagnostic criteria
Draft diagnostic criteria with reference to " new Chinese medicine clinical research guideline " and " Gynecology of Chinese Medicine ".Qualified case enters test, is dispensed into treatment group or matched group by random method.Matched group and treatment group are at the age, and aspects such as the course of disease are learned processing by statistics, there are no significant difference P>0.05.
3, Therapeutic Method
Treatment group: oral capsule of the present invention, each 2, every day 3 times.12d is a course of treatment.
Matched group: give oral FUYANJING, each 2, every day 3 times.12d is a course of treatment.
4, curative effect determinate standard
With the doing well,improving degree is curative effect determinate standard, is divided into recovery from illness, effective, invalid 3 kinds.
Recovery from illness: treatment back subjective symptoms disappears, and hypogastric region and lumbago disappear, and leukorrhagia is normal, and it is thick that the woman examines pelvic cavity and do not have the tenderness adnexa and do not have thickening, increases, and B ultrasonic shows that the inflammatory performance all disappears.
Effectively: subjective symptoms and Signs partly disappear, and hypogastric region, leukorrhagia symptom obviously alleviate, and the woman examines the lower abdomen tenderness and obviously alleviates, and B ultrasonic shows that the inflammatory performance takes a turn for the better.
Invalid: subjective symptoms and Signs do not have obvious change, and lower abdominal pain alleviates slightly, and it is still obvious that the woman examines the pelvic cavity tenderness, and B ultrasonic shows that inflammatory performance nothing obviously changes.
5, observed result
The results are shown in Table 1.
Table 1 treatment group and matched group clinical observation on the therapeutic effect
Group The example number Recovery from illness Effectively Invalid Cure rate % Total effective rate %
The treatment group 90 62 22 6 68.9 93.3
Matched group 82 33 25 24 40.2 70.7
Relatively P<O.01, two groups of total effective rates compare P<0.01 to two groups of obvious effective rates.
As seen from the above table, treatment group cure rate is 68.9%, and total effective rate is 93.3%, and the matched group cure rate is 40.2%, and total effective rate is 70.7%, two group of obvious effective rate, and total effective rate is through X 2Check, there is highly significant difference P value<0.01.Prompting treatment group is better than matched group.
Embodiment 1: be used for the treatment of the preparation of capsule of the medicine of inflammation of woman genetic system
Take by weighing Herba Taraxaci 150g, Herba Glechomae 150g, Radix Angelicae Sinensis 50g, Radix Paeoniae Alba 100g, XUESANQI 50g,, decoct with water 2 times the above five tastes, add for the first time 10 times of decoctings 2 hours, add 8 times of decoctings for the second time and boiled 1 hour, filter, merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), adds ethanol and makes and contain the alcohol amount and reach 65%, left standstill 48 hours, and filtered, it is 1.25 extractum that filtrate recycling ethanol is concentrated into relative density, add dressing, drying is pulverized, granulate, the fill capsule, promptly.
Embodiment 2: be used for the treatment of the preparation of capsule of the medicine of inflammation of woman genetic system
Take by weighing Herba Taraxaci 200g, Herba Glechomae 200g, Radix Angelicae Sinensis 100g, Radix Paeoniae Alba 150g, XUESANQI 100g,, decoct with water 2 times the above five tastes, add for the first time 10 times of decoctings 2 hours, add 8 times of decoctings for the second time and boiled 1 hour, filter, merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), adds ethanol and makes and contain the alcohol amount and reach 65%, left standstill 48 hours, and filtered, it is 1.25 extractum that filtrate recycling ethanol is concentrated into relative density, add dressing, drying is pulverized, granulate, the fill capsule, promptly.
Embodiment 3: be used for the treatment of the preparation of capsule of the medicine of inflammation of woman genetic system
The preparation method that is used for the treatment of the medicine of inflammation of woman genetic system of the present invention, take by weighing Herba Taraxaci 250g, Herba Glechomae 250g, Radix Angelicae Sinensis 150g, Radix Paeoniae Alba 200g, XUESANQI 150g, with the above five tastes, decoct with water 2 times, add 10 times of decoctings 2 hours for the first time, for the second time adding 8 times of decoctings boiled 1 hour, filter, merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), adding ethanol makes and contains the alcohol amount and reach 65%, left standstill 48 hours, and filtered, it is 1.25 extractum that filtrate recycling ethanol is concentrated into relative density, add dressing, drying is pulverized, and granulates, the fill capsule, promptly.
Embodiment 4: be used for the treatment of the preparation of tablet of the medicine of inflammation of woman genetic system
Take by weighing Herba Taraxaci 200g Herba Glechomae 200g, Radix Angelicae Sinensis 100g, Radix Paeoniae Alba 150g, XUESANQI 100g, with the above-mentioned five tastes, decoct with water 2 times, add 10 times of decoctings 2 hours for the first time, add 8 times of decoctings for the second time and boiled 1 hour, filter, merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), adds ethanol and makes and contain the alcohol amount and reach 65%, left standstill 48 hours, filter, it is 1.25 extractum that filtrate recycling ethanol is concentrated into relative density, adds dressing, dry, pulverize, granulate tabletting, sugar coating or film-coat, promptly.
Embodiment 5: be used for the treatment of the preparation of oral liquid of the medicine of inflammation of woman genetic system
Take by weighing Herba Taraxaci 200g Herba Glechomae 200g, Radix Angelicae Sinensis 100g, Radix Paeoniae Alba 150g, XUESANQI 100g,, decoct with water 2 times the above-mentioned five tastes, add for the first time 10 times of decoctings 2 hours, for the second time add 8 times of decoctings and boiled 1 hour, filter merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), add ethanol and make and contain the alcohol amount and reach 65%, left standstill 48 hours, filter, filtrate recycling ethanol is concentrated in right amount, add simple syrup, cold preservation 48 hours filters, add water to ormal weight, adjust pH filters fill to 5.0-7.0, sterilization, promptly.
Embodiment 6: be used for the treatment of the preparation of granule of the medicine of inflammation of woman genetic system
Take by weighing Herba Taraxaci 200g Herba Glechomae 200g, Radix Angelicae Sinensis 100g, Radix Paeoniae Alba 150g, XUESANQI 100g, with the above-mentioned five tastes, decoct with water 2 times, add for the first time 10 times of decoctings 2 hours, add 8 times of decoctings for the second time and boiled 1 hour, filter, merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), adds ethanol and makes and contain the alcohol amount and reach 65%, leaves standstill 48 hours, filter, it is 1.25 extractum that filtrate recycling ethanol is concentrated into relative density, gets 1 part of extractum, with 2 parts of sucrose, 1 part in dextrin, make granule, drying, promptly.
Embodiment 7: be used for the treatment of the preparation of pill of the medicine of inflammation of woman genetic system
Take by weighing Herba Taraxaci 200g, Herba Glechomae 200g, Radix Angelicae Sinensis 100g, Radix Paeoniae Alba 150g, XUESANQI 100g,, decoct with water 2 times the above-mentioned five tastes, add for the first time 10 times of decoctings 2 hours, add 8 times of decoctings for the second time and boiled 1 hour, filter, merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), adds ethanol and makes and contain the alcohol amount and reach 65%, left standstill 48 hours, and filtered, it is 1.25 extractum that filtrate recycling ethanol is concentrated into relative density, add dressing, pill, drying, promptly.
Embodiment 8: be used for the treatment of the preparation of soft capsule of the medicine of inflammation of woman genetic system
Take by weighing Herba Taraxaci 200g Herba Glechomae 200g, Radix Angelicae Sinensis 100g, Radix Paeoniae Alba 150g, XUESANQI 100g,, decoct with water 2 times the above-mentioned five tastes, add for the first time 10 times of decoctings 2 hours, add 8 times of decoctings for the second time and boiled 1 hour, filter, merging filtrate, being evaporated to relative density is 1.08-1.10 (60 ℃), adds ethanol and makes and contain the alcohol amount and reach 65%, left standstill 48 hours, and filtered, it is 1.25 extractum that filtrate recycling ethanol is concentrated into relative density, add dressing, drying is pulverized, granulate, fill soft capsule, promptly.
The above, it only is preferred embodiment of the present invention, be not that the present invention is done any pro forma restriction, any technical solution of the present invention content that do not break away from,, all still belong in the scope of technical solution of the present invention any simple modification, equivalent variations and modification that above embodiment did according to technical spirit of the present invention.

Claims (2)

1, a kind of medicine that is used for the treatment of inflammation of woman genetic system is characterized in that consisting of of crude drug and weight portion thereof:
Herba Taraxaci 150-250 part Herba Glechomae 150-250 part Radix Angelicae Sinensis 50-150 part
Radix Paeoniae Alba 100-200 part XUESANQI 50-150 part.
2, the preparation method that is used for the treatment of the medicine of inflammation of woman genetic system as claimed in claim 1 is characterized in that: with the above five tastes, decoct with water 2 times, add for the first time 10 times of decoctings 2 hours, for the second time add 8 times of decoctings and boiled 1 hour, filter merging filtrate, being evaporated to 60 ℃ of survey relative densities is 1.08-1.10, add ethanol and make and contain the alcohol amount and reach 65%, left standstill 48 hours, filter, filtrate recycling ethanol is concentrated into the extractum that relative density is 1.05-1.35, promptly.
CNB2005100033519A 2005-12-31 2005-12-31 Medicine used for treating inflammation of woman genetic system and its preparation method Expired - Fee Related CN100348247C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100033519A CN100348247C (en) 2005-12-31 2005-12-31 Medicine used for treating inflammation of woman genetic system and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100033519A CN100348247C (en) 2005-12-31 2005-12-31 Medicine used for treating inflammation of woman genetic system and its preparation method

Publications (2)

Publication Number Publication Date
CN1824118A CN1824118A (en) 2006-08-30
CN100348247C true CN100348247C (en) 2007-11-14

Family

ID=36935060

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100033519A Expired - Fee Related CN100348247C (en) 2005-12-31 2005-12-31 Medicine used for treating inflammation of woman genetic system and its preparation method

Country Status (1)

Country Link
CN (1) CN100348247C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112656840A (en) * 2021-02-03 2021-04-16 贵州苗侗百草医药发展有限公司 Medicine for treating human body cavity inflammation and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1146345A (en) * 1995-09-26 1997-04-02 许敬义 Quick-effect traditional Chinese medicine for curing difficult and complicated gynopathy
CN1289110C (en) * 2004-05-25 2006-12-13 贵阳济仁堂药业有限公司 Capsule prepn for treating women's diseases and its prepn process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1146345A (en) * 1995-09-26 1997-04-02 许敬义 Quick-effect traditional Chinese medicine for curing difficult and complicated gynopathy
CN1289110C (en) * 2004-05-25 2006-12-13 贵阳济仁堂药业有限公司 Capsule prepn for treating women's diseases and its prepn process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
逍遥散加减治疗妇科疾病验案 薛俊宏,陈马力,刘丽华.社区医学杂志,第1卷第4期 2003 *

Also Published As

Publication number Publication date
CN1824118A (en) 2006-08-30

Similar Documents

Publication Publication Date Title
CN103127321A (en) Traditional Chinese medicine composition for treating prostatitis and preparation method thereof
CN102362904A (en) Chinese medicinal preparation for tonifying spleen and soothing nerves and production method thereof
CN104840687A (en) Pharmaceutical preparation for treating pelvic inflammation
CN100348247C (en) Medicine used for treating inflammation of woman genetic system and its preparation method
CN102293894B (en) Traditional Chinese medicine composition for treating dysmenorrhea, and preparation method and application thereof
CN104547683B (en) A kind of Chinese medicine composition for treating chronic gastritis and preparation method thereof
CN103735630B (en) A kind of Chinese medicine for the treatment of gout
CN103157048B (en) Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof
CN103070995A (en) Traditional Chinese medicine for curing prostatitis
CN102579986A (en) Chinese medicinal pain-removing mixture for treating migraine
CN101099836B (en) Traditional Chinese medicine composition for treating ischemic apoplexy and preparation process thereof
CN104840703A (en) Medicine preparation for treating breast cancer
CN104815092A (en) Traditional Chinese medicine composition for treating chronic pelvic inflammation
CN104547400A (en) Medicine for treating dysmenorrhea
CN101879227B (en) Chinese medicinal composition for treating protrusion of lumbar intervertebral disci and preparation method thereof
CN104173513B (en) A kind of Chinese medicine or health product being used for the treatment of puerperal constipation
CN101129493B (en) Antineoplastic anti-AIDS pharmaceutical composition and method of preparing the same
CN102357230B (en) Traditional Chinese medicine preparation for treating radiation encephalopathy
CN102552591B (en) Application of pain-relief anti-inflammation ointment to curing cerebral edema of contusion and laceration of brain
CN104887949B (en) A kind of Chinese medicine preparation for the treatment of DCM (dilated cardiomyopathy) and preparation method thereof
CN105169199A (en) Traditional Chinese medicinal composition for treating functional dyspepsia with syndrome of liver-stomach disharmony
CN101129903B (en) Application of disease-eliminating drink in preparing medicine for treating complex of pelvic inflammatory disease and pelvic cavity blood stasis
CN104784567B (en) A kind of pharmaceutical composition for the treatment of urinary system infection
CN102716371A (en) Traditional Chinese medicine composition for curing chronic cough as well as preparation method and usages thereof
CN112472758A (en) Acid-reducing tea for relieving gout and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: GUIZHOU GUTE PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: LIN KAIZHONG; ZHAO HAI; MU RUNHUA;

Effective date: 20071109

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20071109

Address after: 550001 15-A, Tian Kong building, No. 11, jujube Road, Guizhou, Guiyang, China

Patentee after: Guizhou Gute Pharmacy Group Co., Ltd.

Address before: 550002 the Second Affiliated Hospital of Guiyang College of Traditional Chinese Medicine, 83 Fei Shan Street, Guizhou, Guiyang

Co-patentee before: Zhao Hai

Patentee before: Lin Kaizhong

Co-patentee before: Mu Runhua

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20071114

Termination date: 20101231